Could your morning coffee slow Huntington's?

NCT ID NCT03034122

Completed Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether caffeine intake is linked to how Huntington's disease progresses in people who have the gene but not yet symptoms. Researchers followed 77 participants, measuring brain volume changes and thinking skills over time. The goal was to see if caffeine might be a simple lifestyle factor that could influence the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: caffeine (dietary)
What this could lead to: If caffeine is found to slow brain changes, it could point toward a simple dietary way to delay Huntington's symptoms.
What could go wrong: This is a small observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to everyone with Huntington's.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Huntington disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HUNTINGTON DISEASE

Contacts and locations

Locations

AH-HP La Pitié-Salpétrière

Paris, 75679, France
AH-HP, Hôpital Henri Mondor

Paris, France
CHU Montpellier

Montpellier, France
CHU Pellegrin

Bordeaux, France
CHU Purpan

Toulouse, France
CHU de Amiens

Amiens, France
CHU de Angers

Angers, France
CHU de Grenoble

Grenoble, France
CHU de Nancy

Nancy, France
Hôpital Roger Salengro, CHRU

Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.